Orchestra BioMed Holdings's total assets for Q4 2025 were $114.86M, an increase of 9.59% from the previous quarter. OBIO total liabilities were $51.48M for the fiscal quarter, a -15.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.